Global OTC Cough and Cold and Allergy Medicine Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global OTC Cough and Cold and Allergy Medicine Market Research Report 2024
Very few individuals consult doctors for common conditions such as cold, cough and allergies. Cough, cold and allergy medicines are one of most common OTC (over-the-counter) categories, however, physicians recommend their use only for minor health issues. In many countries, there are certain laws enforced on directs sales of these medicines in order to ensure consumer safety.
According to Mr Accuracy reports’s new survey, global OTC Cough and Cold and Allergy Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Cough and Cold and Allergy Medicine market research.
Key manufacturers engaged in the OTC Cough and Cold and Allergy Medicine industry include Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group, Novartis, GlaxoSmithKline, AstraZaneca, Pfizer, Sun Pharmaceutical Industries and Prestige Brands Holdings, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of OTC Cough and Cold and Allergy Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole OTC Cough and Cold and Allergy Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Cough and Cold and Allergy Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Sanofi-Aventis
Johnson and Johnson
Reckitt Benckiser Group
Novartis
GlaxoSmithKline
AstraZaneca
Pfizer
Sun Pharmaceutical Industries
Prestige Brands Holdings
Procter and Gamble
Bristol-Myers Squib
Merck and Co.
Allergen
Segment by Type
Antihistamine
Expectorants
Bronchodialators
Antibiotics
Others
Online
Offline
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The OTC Cough and Cold and Allergy Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global OTC Cough and Cold and Allergy Medicine market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole OTC Cough and Cold and Allergy Medicine market research.
Key manufacturers engaged in the OTC Cough and Cold and Allergy Medicine industry include Sanofi-Aventis, Johnson and Johnson, Reckitt Benckiser Group, Novartis, GlaxoSmithKline, AstraZaneca, Pfizer, Sun Pharmaceutical Industries and Prestige Brands Holdings, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of OTC Cough and Cold and Allergy Medicine were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole OTC Cough and Cold and Allergy Medicine market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global OTC Cough and Cold and Allergy Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Sanofi-Aventis
Johnson and Johnson
Reckitt Benckiser Group
Novartis
GlaxoSmithKline
AstraZaneca
Pfizer
Sun Pharmaceutical Industries
Prestige Brands Holdings
Procter and Gamble
Bristol-Myers Squib
Merck and Co.
Allergen
Segment by Type
Antihistamine
Expectorants
Bronchodialators
Antibiotics
Others
Segment by Application
Online
Offline
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The OTC Cough and Cold and Allergy Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source